This new report provides analysis of Phibro’s capabilities, goals and strategies in the global animal health market, including:

- Sales and growth
- Extensive portfolio of antibiotics and antibacterials
- Sales force, sales offices and distribution network
- Animal health R&D facilities
- Biotay acquisition

The report also provides assessment of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, including discussion of such issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and includes five-year forecasts for:

- Major market segments
- Key geographic regions